Inhibition of proinflammatory cytokine production by pravastatin

Lancet. 1999 Mar 20;353(9157):983-4. doi: 10.1016/S0140-6736(98)05917-0.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticholesteremic Agents / therapeutic use*
  • Cholesterol / blood
  • Cytokines / antagonists & inhibitors*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / drug therapy
  • Inflammation Mediators / antagonists & inhibitors*
  • Interleukin-1 / antagonists & inhibitors
  • Interleukin-6 / antagonists & inhibitors
  • Interleukin-8 / antagonists & inhibitors
  • Male
  • Middle Aged
  • Pravastatin / therapeutic use*
  • Receptors, Interleukin-1 / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anticholesteremic Agents
  • Cytokines
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Inflammation Mediators
  • Interleukin-1
  • Interleukin-6
  • Interleukin-8
  • Receptors, Interleukin-1
  • Tumor Necrosis Factor-alpha
  • Cholesterol
  • Pravastatin